Acadia Pharmaceuticals Inc. (ACAD) Short Interest
Nasdaq • ACAD • US0042251084
As of Nov 3, 2026, ORTEX estimates 6.9% of free float is sold short, 5.8 days to cover, cost to borrow 0.38%.
Nasdaq • ACAD • US0042251084
As of Nov 3, 2026, ORTEX estimates 6.9% of free float is sold short, 5.8 days to cover, cost to borrow 0.38%.
This page tracks how heavily Acadia Pharmaceuticals Inc. (Nasdaq:ACAD) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has a market capitalization of $3.7B. Last close $21.50 (as of 2026-11-05); 52-week range $18.39 to $30.96. ORTEX data as of 2026-11-03: short interest is 6.94% of free float, 5.8 days to cover and the average cost to borrow is 0.38%.